Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
TCDA
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
finbold.com
11 hours ago
pennystocks.com
11 hours ago
proactiveinvestors.com
14 hours ago
businesswire.com
16 hours ago
businesswire.com
16 hours ago
newsfilecorp.com
19 hours ago
Earnings Growth
YoY
Current
Estimates
Q2.20
N/A
-1.16
vs -0.75
Q3.20
N/A
-1.55
vs -0.89
Q4.20
N/A
-1.09
vs -1.17
Q1.21
N/A
-1.06
vs -1.49
Q2.21
N/A
-0.67
vs -1.16
Q3.21
N/A
-0.79
vs -1.55
Q4.21
N/A
-1.00
vs -1.09
Q1.22
N/A
-0.51
vs -1.06
Q2.22
N/A
-0.49
vs -0.67
Q3.22
N/A
-0.44
vs -0.79
Sales Growth
YoY
Current
Estimates
Q2.20
NA
NA vs NA
Q3.20
NA
NA vs NA
Q4.20
NA
NA vs NA
Q1.21
NA
NA vs NA
Q2.21
NA
NA vs NA
Q3.21
NA
NA vs NA
Q4.21
NA
NA vs NA
Q1.22
NA
NA vs NA
Q2.22
NA
NA vs NA
Q3.22
NA
NA vs NA
Return on Equity
QoQ
Q2.20
-25%
-0.25
vs -0.37
Q3.20
-48%
-0.48
vs -0.25
Q4.20
0%
-0.00
vs -0.48
Q1.21
-87%
-0.87
vs -0.00
Q2.21
-96%
-0.96
vs -0.87
Q3.21
-2086%
-20.86
vs -0.96
Q4.21
-24791%
-247.91
vs -20.86
Q1.22
+35%
0.35
vs -247.91
Q2.22
+27%
0.27
vs 0.35
Q3.22
+20%
0.2
vs 0.27
Institutionnal Ownership
QoQ
Q1.21
106
106
vs 116
-9%
Q2.21
89
89
vs 106
-16%
Q3.21
78
78
vs 89
-12%
Q4.21
88
88
vs 78
13%
Q1.22
102
102
vs 88
16%
Q2.22
128
128
vs 102
25%
Q3.22
157
157
vs 128
23%
Q4.22
82
82
vs 157
-48%
Q1.23
3
3
vs 82
-96%
Q2.23
1
1
vs 3
-67%
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(N/A)
Number of analyst
0
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
After-hours NaN$
0.00 (0.00%)
Relative Strenght
Volume Buzz
147%
Earning Acce
Yes
Dist 52w H.
99%Relative Strength
TCDA
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How TCDA compares to sector?
TCDA
0x